axogen的封面图片
axogen

axogen

生物技术研究

Alachua,Fl 18,513 位关注者

revolutionizing the science of nerve repair?

关于我们

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen’s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.

网站
https://www.axogeninc.com
所属行业
生物技术研究
规模
201-500 人
总部
Alachua,Fl
类型
上市公司
创立
2002
领域
Medical Device、Peripheral Nerve Repair、Biotechnology、Tissue Engineering、Regenerative Medicine、Translational Science、Processed Nerve Allograft、Biologics、Life Science和Breast Reconstruction Nerve Repair

地点

axogen员工

动态

  • 查看axogen的组织主页

    18,513 位关注者

    Join our expert panel of peripheral nerve surgeons for an interactive session designed to deepen your understanding of complex nerve injury repair. Through engaging case presentations and review of the latest clinical data, the panel will explore the critical importance of assessing the zone of injury, addressing real-world challenges in treating painful neuromas, and methods for evaluating non-transected nerve injuries. Attendees will gain valuable insights into cutting-edge surgical strategies, practical techniques, and innovative approaches to optimize patient outcomes. This is a unique opportunity to learn from renowned experts, discuss effective clinical approaches, and gain technical pearls to incorporate into your own operating practices.

    • 该图片无替代文字
  • 查看axogen的组织主页

    18,513 位关注者

    Extremity surgeons see a significant amount of nerve damage with a range of causes, including trauma and compression. Each patient presents a unique scenario depending on the mechanism of injury, timing of surgery and nerve injured. You need a nerve repair partner with technologies for all of your nerve needs. Join Axogen at IFSSH in booth 205 to see how these technologies can benefit your practice and patients.

  • 查看axogen的组织主页

    18,513 位关注者

    Watch the full recording of Axogen's Analyst & Investor Day!?? CEO Michael Dale and our leadership team showcased our innovative nerve repair algorithm, strategic growth initiatives, and financial outlook.? See how we’re working to make nerve care the expected standard & drive impact for patients and investors alike.?? Watch the full replay here: https://lnkd.in/e-2QVYAF

    • 该图片无替代文字
  • 查看axogen的组织主页

    18,513 位关注者

    Axogen is excited to attend the ACFAS Scientific Conference in Phoenix. We look forward to sharing the latest in nerve protection and reconstruction technologies with the country's leading podiatrists in the pursuit of advancing the art and science of foot, ankle, and lower extremity surgery. See you there!

    • 该图片无替代文字
  • 查看axogen的组织主页

    18,513 位关注者

    Today we shared our Q4 and full-year 2024 earnings results, marking a strong year of growth! - Q4 revenue: $49.4M (+15.1% YoY) - Full-year revenue: $187.3M (+17.8% YoY) - Positive cash flow in 2024, a major milestone in our financial performance Join us on March 4th in Tampa, FL, for our Analyst & Investor Day! Our leadership team will discuss our growth strategy, innovation, and vision for the future. Can't attend in person? No problem—a live webcast and 90-day replay will be available. We’re excited for what’s ahead, as we remain focused on advancing our mission to make peripheral nerve care the standard of care for all patients. https://lnkd.in/eGVrSMpG https://lnkd.in/ezmb2_pv

  • 查看axogen的组织主页

    18,513 位关注者

    Axogen is headed to New Orleans for the 34th annual NASBS meeting. Join our nerve experts to discuss how Axogen can help head and neck surgeons restore form and function to patients with minimal morbidity and more consistent outcomes.

    • 该图片无替代文字
  • 查看axogen的组织主页

    18,513 位关注者

    We’re thrilled to share our preliminary fourth-quarter results, highlighting continued growth and enhanced execution of our commercial strategies in 2024. "We are pleased with our fourth-quarter and full-year 2024 performance, which reflects continued improvements in effectiveness and efficiency across the business," said Michael Dale, President and CEO of Axogen. As we move forward, we will remain focused on advancing our mission to make peripheral nerve care the standard of care for all patients. Stay tuned as we continue to drive meaningful progress in this critical area of healthcare. #Axogen #MedTech #Q42024Results #MedicalDevice #BioTech #nerverepair https://lnkd.in/e3vVgk9k

相似主页

查看职位

融资

axogen 共 10 轮

上一轮

上市后股权

US$41,000,000.00

Crunchbase 上查看更多信息